An enzyme-responsive and transformable PD-L1 blocking peptide-photosensitizer conjugate enables efficient photothermal immunotherapy for breast cancer

Mild photothermal therapy combined with immune checkpoint blockade has received increasing attention for the treatment of advanced or metastatic cancers due to its good therapeutic efficacy. However, it remains a challenge to facilely integrate the two therapies and make it potential for clinical tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yanan, Lyu, Bochen, Yang, Chang, He, Bing, Zhang, Hua, Wang, Xueqing, Zhang, Qiang, Dai, Wenbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519467/
https://www.ncbi.nlm.nih.gov/pubmed/36203955
http://dx.doi.org/10.1016/j.bioactmat.2022.08.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519467/
https://www.ncbi.nlm.nih.gov/pubmed/36203955
http://dx.doi.org/10.1016/j.bioactmat.2022.08.020

Ejemplares similares